Selecting the appropriate viral vector is crucial to the success of your therapeutic product. While adenovirus (AV) and adeno-associated virus (AAV) are often the most widely used, other niche vector types are gaining popularity for a variety of clinical applications. Each vector is associated with a unique set of characteristics, which can have significant implications for the manufacturing strategy.
Our comprehensive guide provides the insights you need to make informed decisions and achieve success in your cell or gene therapy development. The viral vector selection guide covers: